Protein farnesyltransferase inhibitors and progeria

This publication has 49 references indexed in Scilit:

• Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis
  Journal of Lipid Research, 2005
• Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24
  Biochemical Journal, 2005
• Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24 -deficient mice
  Proceedings of the National Academy of Sciences, 2004
• The Nuclear Envelope and Human Disease
  Physiology, 2004
• Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome
  Nature, 2003
• Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect
  Proceedings of the National Academy of Sciences, 2002
• Life at the edge: the nuclear envelope and human disease
  Nature Reviews Molecular Cell Biology, 2002
• The A-Type Lamins: Nuclear Structural Proteins as a Focus for Muscular Dystrophy and Cardiovascular Diseases
  Published by Elsevier ,2001
• The nuclear envelope, muscular dystrophy and gene expression
  Trends in Cell Biology, 2000
• Posttranslational modification of the Ha-ras oncogene protein: evidence for a third class of protein carboxyl methyltransferases.
  Proceedings of the National Academy of Sciences, 1988